К содержанию
MMadical AI Use

Source record

Worklist triage for critical findings on chest radiographs

Отчет поставщикаНовость

Текст показан по-английски, пока нет перевода.

The source is the U.S. FDA list of AI/ML-enabled medical devices, used here with a source date of 1 May 2024. It is a public catalog of authorized devices, not a trial and not a comparison of chest-radiograph products. This entry uses the list only to point at a class of cleared worklist-triage tools, including products such as Lunit INSIGHT CXR, Annalise Enterprise CXR, and qXR. It reports no pooled sensitivity or specificity.

Source date
1 мая 2024 г. · Год 2024
Evidence label
Отчет поставщика
Source type
Новость

Citation

U.S. FDA AI/ML-enabled device list

U.S. Food and Drug Administration. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. Public device list, dated in this index as 1 May 2024. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices

Key public facts

  • The page is FDA’s list of AI/ML-enabled devices, not a single-product study and not a head-to-head trial.
  • This index date for the page is 1 May 2024. The list itself changes as new devices are authorized.
  • The clinical job described is worklist triage for possible urgent chest-radiograph findings, such as pneumothorax, before the formal report.
  • Names often cited for this job include Lunit INSIGHT CXR, Annalise Enterprise CXR, and qXR. Their labeled uses are not interchangeable.
  • No pooled performance figure is stated. A flagged study still needs a radiologist’s report.
Original link

Opens the publisher page in a new tab.

Back to the case

Запись для обучения и обзора рынка. Не совет и не поддержка.

Спонсор

Доберитесь до клинических читателей этого указателя.

О спонсорстве